429 related articles for article (PubMed ID: 10738844)
1. Tolerability of atypical antipsychotics.
Stanniland C; Taylor D
Drug Saf; 2000 Mar; 22(3):195-214. PubMed ID: 10738844
[TBL] [Abstract][Full Text] [Related]
2. An open, large, 6-month naturalistic study of outcome in schizophrenic outpatients, treated with olanzapine.
Krzystanek M; Krupka-Matuszczyk I
Hum Psychopharmacol; 2011 Jan; 26(1):81-5. PubMed ID: 23055416
[TBL] [Abstract][Full Text] [Related]
3. Tolerability profile of atypical antipsychotics in children and adolescents.
Stigler KA; Potenza MN; McDougle CJ
Paediatr Drugs; 2001; 3(12):927-42. PubMed ID: 11772153
[TBL] [Abstract][Full Text] [Related]
4. Safety and tolerability: how do newer generation "atypical" antipsychotics compare?
Tandon R
Psychiatr Q; 2002; 73(4):297-311. PubMed ID: 12418358
[TBL] [Abstract][Full Text] [Related]
5. Novel antipsychotics, extrapyramidal side effects and tardive dyskinesia.
Barnes TR; McPhillips MA
Int Clin Psychopharmacol; 1998 Mar; 13 Suppl 3():S49-57. PubMed ID: 9690971
[TBL] [Abstract][Full Text] [Related]
6. Effects of newer antipsychotics on extrapyramidal function.
Tarsy D; Baldessarini RJ; Tarazi FI
CNS Drugs; 2002; 16(1):23-45. PubMed ID: 11772117
[TBL] [Abstract][Full Text] [Related]
7. The relationship of pharmacology to side effects.
Casey DE
J Clin Psychiatry; 1997; 58 Suppl 10():55-62. PubMed ID: 9265918
[TBL] [Abstract][Full Text] [Related]
8. Adverse effects of atypical antipsychotics : differential risk and clinical implications.
Haddad PM; Sharma SG
CNS Drugs; 2007; 21(11):911-36. PubMed ID: 17927296
[TBL] [Abstract][Full Text] [Related]
9. Benefit-risk assessment of atypical antipsychotics in the treatment of schizophrenia and comorbid disorders in children and adolescents.
Toren P; Ratner S; Laor N; Weizman A
Drug Saf; 2004; 27(14):1135-56. PubMed ID: 15554747
[TBL] [Abstract][Full Text] [Related]
10. The SOHO (Schizophrenia Outpatient Health Outcome) study: implications for the treatment of schizophrenia.
Haro JM; Salvador-Carulla L
CNS Drugs; 2006; 20(4):293-301. PubMed ID: 16599647
[TBL] [Abstract][Full Text] [Related]
11. Atypical antipsychotics: mechanism of action.
Seeman P
Can J Psychiatry; 2002 Feb; 47(1):27-38. PubMed ID: 11873706
[TBL] [Abstract][Full Text] [Related]
12. A review of the effect of atypical antipsychotics on weight.
Nasrallah H
Psychoneuroendocrinology; 2003 Jan; 28 Suppl 1():83-96. PubMed ID: 12504074
[TBL] [Abstract][Full Text] [Related]
13. Striatal dopamine-2 receptor occupancy as measured with [123I]iodobenzamide and SPECT predicted the occurrence of EPS in patients treated with atypical antipsychotics and haloperidol.
Tauscher J; Küfferle B; Asenbaum S; Tauscher-Wisniewski S; Kasper S
Psychopharmacology (Berl); 2002 Jun; 162(1):42-9. PubMed ID: 12107616
[TBL] [Abstract][Full Text] [Related]
14. Bodyweight gain with atypical antipsychotics. A comparative review.
Wetterling T
Drug Saf; 2001 Jan; 24(1):59-73. PubMed ID: 11219487
[TBL] [Abstract][Full Text] [Related]
15. Adverse effects of antipsychotic agents. Do newer agents offer advantages?
Owens DG
Drugs; 1996 Jun; 51(6):895-930. PubMed ID: 8736614
[TBL] [Abstract][Full Text] [Related]
16. Extrapyramidal symptoms with atypical antipsychotics : incidence, prevention and management.
Pierre JM
Drug Saf; 2005; 28(3):191-208. PubMed ID: 15733025
[TBL] [Abstract][Full Text] [Related]
17. Second-generation (atypical) antipsychotics and metabolic effects: a comprehensive literature review.
Newcomer JW
CNS Drugs; 2005; 19 Suppl 1():1-93. PubMed ID: 15998156
[TBL] [Abstract][Full Text] [Related]
18. Tardive dyskinesia in the era of typical and atypical antipsychotics. Part 2: Incidence and management strategies in patients with schizophrenia.
Margolese HC; Chouinard G; Kolivakis TT; Beauclair L; Miller R; Annable L
Can J Psychiatry; 2005 Oct; 50(11):703-14. PubMed ID: 16363464
[TBL] [Abstract][Full Text] [Related]
19. The use of atypical antipsychotics in the management of schizophrenia.
Campbell M; Young PI; Bateman DN; Smith JM; Thomas SH
Br J Clin Pharmacol; 1999 Jan; 47(1):13-22. PubMed ID: 10073734
[TBL] [Abstract][Full Text] [Related]
20. A review of atypical antipsychotic drugs versus conventional medication in schizophrenia.
Luft B; Taylor D
Expert Opin Pharmacother; 2006 Sep; 7(13):1739-48. PubMed ID: 16925501
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
